Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Show More...
-
Website http://www.codiagnostics.com
-
Sector Healthcare
-
Industry Diagnostics & Research
-
Last Quote 0.26 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.18 -0.17 -0.63 -0.5 -0.36 -0.32 Dividends USD Payout Ratio % * Shares Mil 11.0 11.0 11.0 12.0 17.0 18.0 Book Value Per Share * USD 0.42 0.010 0.19 0.7 Free Cash Flow Per Share * USD -0.23 -0.34 -0.32 Return on Assets % -550.82 -231.43 -233.6 -201.81 -328.81 -44.3 Financial Leverage (Average) 1.21 1.28 1.07 Return on Equity % -449.31 -47.65 Return on Invested Capital % -186.31 -48.01 Interest Coverage -26.17 -7.01 -21.43 -45.48 -57.21 Current Ratio 0.15 0.31 7.09 0.45 4.82 16.43 Quick Ratio 0.03 0.26 5.63 0.41 3.12 15.44 Debt/Equity